Drug Discovery and Clinic Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Drug Discovery and Clinic General Information
Description
Developer of pharmaceutical drugs designed to research and offer potential new drugs for the treatment of acute myeloid leukemia. The company offers treatment of leukemia by the development of dihydroorotate dehydrogenase inhibitors that could significantly improve patients' survival, enabling patients to significantly improve their survival rate.
Contact Information
Website
www.ddcpharmaceutical.comCorporate Office
- Via Gioacchino Quarello 15/A
- 10135 Turin
- Italy
Corporate Office
- Via Gioacchino Quarello 15/A
- 10135 Turin
- Italy
Drug Discovery and Clinic Timeline
Drug Discovery and Clinic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 23-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC | 17-Nov-2022 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Apr-2021 | Completed | Startup | |||
| 3. Grant | Completed | Startup | ||||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Drug Discovery and Clinic Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Drug Discovery and Clinic Patents
Drug Discovery and Clinic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4788670-A2 | Prodrugs of human dihydroorotate dehydrogenase (dhodh) inhibitors | Pending | 06-Oct-2023 | ||
| AU-2024356817-A1 | Prodrugs of human dihydroorotate dehydrogenase (h dhodh) inhibitors | Pending | 06-Oct-2023 | ||
| WO-2025074343-A2 | Prodrugs of human dihydroorotate dehydrogenase (hdhodh) inhibitors | Inactive | 06-Oct-2023 | ||
| WO-2025074343-A3 | Prodrugs of human dihydroorotate dehydrogenase (hdhodh) inhibitors | Inactive | 06-Oct-2023 | ||
| AU-2021376883-A1 | Pyrazolo derivatives as human dihydroorotate dehydrogenase (hdhodh) inhibitors for use as antivirals | Inactive | 13-Nov-2020 | A61K31/437 |
Drug Discovery and Clinic Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 2i3T | Accelerator/Incubator | |||
| Utopia SIS | Venture Capital | Minority | ||
| G-Factor | Accelerator/Incubator | Minority | ||
| G-Force | Venture Capital | Minority | ||
| University of Turin | University |
Drug Discovery and Clinic FAQs
-
When was Drug Discovery and Clinic founded?
Drug Discovery and Clinic was founded in 2020.
-
Where is Drug Discovery and Clinic headquartered?
Drug Discovery and Clinic is headquartered in Turin, Italy.
-
What industry is Drug Discovery and Clinic in?
Drug Discovery and Clinic’s primary industry is Drug Discovery.
-
Is Drug Discovery and Clinic a private or public company?
Drug Discovery and Clinic is a Private company.
-
What is Drug Discovery and Clinic’s current revenue?
The current revenue for Drug Discovery and Clinic is .
-
How much funding has Drug Discovery and Clinic raised over time?
Drug Discovery and Clinic has raised $1.5M.
-
Who are Drug Discovery and Clinic’s investors?
2i3T, Utopia SIS, G-Factor, G-Force, and University of Turin are 5 of 6 investors who have invested in Drug Discovery and Clinic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
